Parametric Portfolio Associates’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.88M | Buy |
185,533
+116,057
| +167% | +$1.18M | ﹤0.01% | 2449 |
|
|
2021
Q4 | $1.16M | Buy |
69,476
+7,812
| +13% | +$130K | ﹤0.01% | 2715 |
|
|
2021
Q3 | $2.89M | Buy |
61,664
+4,367
| +8% | +$205K | ﹤0.01% | 2188 |
|
|
2021
Q2 | $3.49M | Buy |
57,297
+4,443
| +8% | +$271K | ﹤0.01% | 2104 |
|
|
2021
Q1 | $3.26M | Buy |
52,854
+19,687
| +59% | +$1.21M | ﹤0.01% | 2458 |
|
|
2020
Q4 | $2.36M | Buy |
33,167
+3,801
| +13% | +$270K | ﹤0.01% | 2557 |
|
|
2020
Q3 | $1.1M | Sell |
29,366
-667
| -2% | -$25K | ﹤0.01% | 2860 |
|
|
2020
Q2 | $979K | Buy |
30,033
+13,651
| +83% | +$445K | ﹤0.01% | 2932 |
|
|
2020
Q1 | $475K | Sell |
16,382
-2,741
| -14% | -$79.5K | ﹤0.01% | 3186 |
|
|
2019
Q4 | $670K | Buy |
19,123
+1,194
| +7% | +$41.8K | ﹤0.01% | 3258 |
|
|
2019
Q3 | $385K | Buy |
+17,929
| New | +$385K | ﹤0.01% | 3435 |
|